Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
896.8 USD | +0.32% | -0.87% | +2.11% |
Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
Apr. 17 | The market is pinning its hopes on earnings reports |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.11% | 96.37B | |
-3.10% | 102B | |
-1.80% | 21.37B | |
-17.75% | 20.92B | |
-6.91% | 18.64B | |
-42.00% | 16.4B | |
-28.19% | 13.53B | |
+0.18% | 13.28B | |
+19.90% | 10.85B | |
-23.23% | 8.4B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc. Presents at Citi 15th Annual Biopharma Virtual Conference 2020, Sep-09-2020 08